Intellia Therapeutics

NTLA

Rank 1613

Country USA

Exchange NASDAQ

Currency USD

Sector LIFE SCIENCES

Industry IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Address 40 ERIE STREET, SUITE 130, CAMBRIDGE, MA, US

Intellia Therapeutics - Key figures

Market cap 3.69 Billion

Revenue 33.05 Million

Profit -186,754,000

P/E Ratio No information

P/s Ratio 111.53

Intellia Therapeutics, Inc., a genome editing company, is focused on developing therapies.

The company is headquartered in Cambridge, Massachusetts.